Asiaticoside Mitigates Alzheimer's Disease Pathology by Attenuating Inflammation and Enhancing Synaptic Function.

Alzheimer’s disease Asiaticoside inflammation p38 MAPK synapse

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
26 Jul 2023
Historique:
received: 08 06 2023
revised: 21 07 2023
accepted: 24 07 2023
medline: 12 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder, hallmarked by the accumulation of amyloid-β (Aβ) plaques and neurofibrillary tangles. Due to the uncertainty of the pathogenesis of AD, strategies aimed at suppressing neuroinflammation and fostering synaptic repair are eagerly sought. Asiaticoside (AS), a natural triterpenoid derivative derived from Centella asiatica, is known for its anti-inflammatory, antioxidant, and wound-healing properties; however, its neuroprotective function in AD remains unclear. Our current study reveals that AS, when administered (40 mg/kg) in vivo, can mitigate cognitive dysfunction and attenuate neuroinflammation by inhibiting the activation of microglia and proinflammatory factors in Aβ

Identifiants

pubmed: 37569347
pii: ijms241511976
doi: 10.3390/ijms241511976
pmc: PMC10418370
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Nature Science Foundation of Jiangsu Province
ID : BK20221051

Références

Mol Neurodegener. 2010 Dec 13;5:57
pubmed: 21144050
Lancet Neurol. 2010 Jul;9(7):702-16
pubmed: 20610346
J Neurosci Res. 1999 Nov 1;58(3):417-25
pubmed: 10518115
Brain Behav Immun. 2017 Jul;63:160-175
pubmed: 28027926
Curr Neuropharmacol. 2007 Dec;5(4):232-43
pubmed: 19305740
Front Immunol. 2023 May 01;14:1192940
pubmed: 37197654
J Neuroinflammation. 2017 Mar 14;14(1):52
pubmed: 28288671
CNS Drugs. 2011 Mar;25(3):213-26
pubmed: 21323393
Life Sci. 2021 Jul 1;276:119129
pubmed: 33515559
BMC Complement Altern Med. 2015 Apr 14;15:118
pubmed: 25880304
Molecules. 2017 Aug 02;22(8):
pubmed: 28767069
Neurobiol Aging. 2018 Mar;63:165
pubmed: 29173836
J Alzheimers Dis. 2001 Feb;3(1):41-48
pubmed: 12214071
J Neuroinflammation. 2019 Mar 14;16(1):62
pubmed: 30871577
Biomaterials. 2019 Dec;224:119491
pubmed: 31546096
J Cell Mol Med. 2023 Mar;27(5):593-608
pubmed: 36756687
Expert Rev Neurother. 2009 Nov;9(11):1635-45
pubmed: 19903023
Nat Immunol. 2010 Feb;11(2):155-61
pubmed: 20037584
Science. 2002 Oct 25;298(5594):789-91
pubmed: 12399581
J Ethnopharmacol. 2021 Mar 1;267:113468
pubmed: 33049345
Science. 1999 Dec 24;286(5449):2514-7
pubmed: 10617468
Curr Neuropharmacol. 2020;18(11):1106-1125
pubmed: 32484110
PLoS One. 2012;7(4):e35090
pubmed: 22563377
Neurology. 2007 May 1;68(18):1501-8
pubmed: 17470753
Neurochem Res. 2012 May;37(5):903-10
pubmed: 22311128
Biomater Sci. 2021 Jul 27;9(15):5227-5236
pubmed: 34190240
J Alzheimers Dis. 2005 Apr;7(2):103-17; discussion 173-80
pubmed: 15851848
J Cell Sci. 2019 Jul 5;132(13):
pubmed: 31189538
Dev Cell. 2014 Sep 29;30(6):673-87
pubmed: 25199687
Neurobiol Aging. 2009 Jul;30(7):1125-34
pubmed: 18006193
Nucleic Acids Res. 2015 Jan;43(Database issue):D1049-56
pubmed: 25428369
Lancet Oncol. 2005 May;6(5):322-7
pubmed: 15863380
Exp Neurol. 2013 Dec;250:176-88
pubmed: 24047952
Lancet Neurol. 2015 Apr;14(4):388-405
pubmed: 25792098
N Engl J Med. 2001 Nov 22;345(21):1515-21
pubmed: 11794217
Front Cell Dev Biol. 2021 Jan 28;9:635636
pubmed: 33585492
Adv Drug Deliv Rev. 2020;154-155:102-122
pubmed: 32650041
Drugs Aging. 2011 Jul 1;28(7):539-46
pubmed: 21721598
N Engl J Med. 2013 Jan 10;368(2):117-27
pubmed: 23150934
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:187-194
pubmed: 29169997
J Neurosci. 2003 Apr 1;23(7):2665-74
pubmed: 12684452
Front Pharmacol. 2018 Jan 30;9:28
pubmed: 29441018
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
Cell. 2010 Aug 6;142(3):387-97
pubmed: 20655099
Neurobiol Aging. 2006 Oct;27(10):1372-84
pubmed: 16289476
Biochem Soc Trans. 2006 Dec;34(Pt 6):1018-23
pubmed: 17073741
Cell Death Dis. 2016 Jan 21;7:e2068
pubmed: 26794661
Nat Commun. 2019 May 13;10(1):2145
pubmed: 31086184

Auteurs

Sai Liu (S)

State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.

Long Chen (L)

State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.

Jinran Li (J)

State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.

Yuan Sun (Y)

State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.

Yue Xu (Y)

Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.

Zhaoxing Li (Z)

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing 210009, China.

Zheying Zhu (Z)

School of Pharmacy, The University of Nottingham, Nottingham NG7 2RD, UK.

Xinuo Li (X)

State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
Jiangsu Provincial Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China.

Classifications MeSH